Improved CNS control with the addition of chemotherapy to osimertinib: A devil's bargain? Correspondence

  

Authors:	Yu, Y.; Miao, E.; Pike, L. R. G.
Title:	Improved CNS control with the addition of chemotherapy to osimertinib: A devil's bargain?
Keywords:	cancer survival; treatment response; overall survival; cancer combination chemotherapy; monotherapy; cancer radiotherapy; antineoplastic agent; letter; progression free survival; antineoplastic combined chemotherapy protocols; carcinoma, non-small-cell lung; lung neoplasms; pyrimidines; central nervous system tumor; central nervous system neoplasms; lung tumor; cognition; stereotactic radiosurgery; aniline compounds; drug therapy; indoles; pyrimidine derivative; indole derivative; non small cell lung cancer; central nervous system metastasis; whole brain radiotherapy; acrylamides; aniline derivative; humans; human; acrylamide derivative; osimertinib
Journal Title:	Journal of Clinical Oncology
Volume:	42
Issue:	17
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2024-06-10
Start Page:	2107
End Page:	2108
Language:	English
DOI:	10.1200/jco.23.02699
PUBMED:	38569123
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85195435397&doi=10.1200%2fJCO.23.02699&partnerID=40&md5=a270494713ad97b91c6463daf25366f6
Notes:	Letter -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/216907